Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
23:01:53 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 339.97 USD | -0.81% |
|
+0.74% | +23.56% |
| 09-04 | US companies face rise in cyber attacks | RE |
| 09-01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 23,926 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 20.87% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 23,422 | 22,887 | 22,467 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 21.95% | -2.29% | -1.83% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 39.6x | 34.5x | 30.8x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 7.64x | 6.67x | 5.9x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.5x | 2.3x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.09x | 6.67x | 6.21x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 6.94x | 6.38x | 5.83x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 24.9x | 22x | 19.4x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 30.9x | 27x | 23.6x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 54.4x | 40.3x | 31x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.84% | 2.48% | 3.23% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.121 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.27% | 0.29% | 0.33% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.2% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,375 | 3,587 | 3,854 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 940.4 | 1,041 | 1,159 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.5 | 848.4 | 952.3 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 614.5 | 701.2 | 778 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -1,039 | -1,458 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 339.97 | 339.97 | 339.97 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 2/17/22 A | 2/16/23 A | 2/15/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 39.65x | 6.94x | 24.91x | 0.27% | 23.93B | |
| 31.08x | 4.2x | 16.15x | 2.37% | 187B | |
| 19.92x | 3.63x | 12.95x | 3.01% | 120B | |
| 18.12x | 0.21x | 13.19x | 0.72% | 63.15B | |
| 29.59x | 7.29x | 18.82x | 1.35% | 51.75B | |
| 35.6x | 3.43x | 11.76x | 2.12% | 50.32B | |
| 35.23x | 6.2x | 19.45x | -.--% | 33.17B | |
| 47.24x | 1.35x | 12.52x | 0.2% | 32.1B | |
| 18.12x | 2.89x | 10.23x | 1.53% | 22.99B | |
| 48.53x | 6.56x | 21.1x | 0.44% | 21.52B | |
| Average | 32.31x | 4.27x | 16.11x | 1.2% | 60.68B | |
| Weighted average by Cap. | 29.31x | 3.97x | 15.36x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
